Pattern Bioscience, Inc.
AUSTIN, TX · Founded 2014 · CIK 0001735812 · Medtech · Private
Rapid phenotypic bacterial identification and antimicrobial susceptibility testing (ID/AST) system
pattern.bio →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $83M
- 5 Form D · Aug 2025
- 14 months since last filing
- Contracts
- $23M
- 1 award · Health and Human S
- #37 of 4531 in medtech
- Patents
- 34
- 14 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,550,000 | |
| Private capital raised | Form D · SEC | $5,499,999 | |
| Private capital raised | Form D · SEC | $6,000,001 | |
| Private capital raised | Form D · SEC | $23,499,993 | |
| Federal contract | Department of Health and Human Services · Verification, Clinical Evaluation, And Fda Clearance Of The World's First Culture-free Phenotypic Id/ast Diagnostic Platform | $22,500,000 | |
| Private capital raised | Form D · SEC | $44,221,343 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 34 | FORT DEFIANCE INDUSTRIES LLC | $27M | — |
| 35 | QUANTUM APPLIED SCIENCE & RESEARCH INC | $25M | — |
| 36 | Itamar Medical | $24M | $15M |
| 37 | Pattern Bioscience, Inc. | $23M | $83M |
| 38 | Nano Terra, Inc. | $22M | $26M |
| 39 | VCOM3D INC | $22M | — |
| 40 | ELECTRONIC BIOSCIENCES, INC. | $21M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Nicolas ArabDirector · Executive Officer · Promoter
- Patrick BalthropDirector
- Patrick Balthrop, Sr.Director
- Carey-Ann BurnhamDirector · Executive Officer
- Bryan GammonDirector
- Junjun GaoDirector
- Ross JohnsonExecutive Officer · Promoter
- Oscar MarxDirector
- Oscar Marx IIIDirector
- Scott MendelDirector
- Nicholas NaclerioDirector
- Johnson RossExecutive Officer
- Greg WoodDirector
- Gregory WoodDirector
Patents
- Method For Characterizing Cellsapplication
- Compositions And Methods For Cellular Phenotype Assessment Of A Sample Using Confined Volume Arraysapplication
- Compositions And Methods For Cellular Phenotype Assessment Of A Sample Using Confined Volume Arraysgranted
- Microfluidic Chips Including a Gutter to Facilitate Loading Thereof and Related Methodsgranted
- Compositions And Methods For Disease Diagnosis Using Single Cell Analysisgranted
- Microfluidic Chips Including a Gutter Having a Trough and a Ridge to Facilitate Loading Thereof and Related Methodsgranted
- Apparatuses for Contactless Loading and Imaging of Microfluidic Chips and Related Methodsapplication
- Methods For Preventing Inter-droplet Transfer Of A Fluorescent Product In Aqueous Droplets By Forming A Soluble Complex With Cyclodextrinapplication
- Apparatuses for Contactless Loading and Imaging of Microfluidic Chips and Related Methodsgranted
- Methods And Apparatus For Forming 2-DIMENSIONAL Drop Arraysapplication
- Methods And Apparatus For Forming 2-DIMENSIONAL Drop Arraysgranted
- Chip Imaging Module Arraygranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.